Free Trial

AREX Capital Management LP Has $19.45 Million Holdings in Enhabit, Inc. (NYSE:EHAB)

Enhabit logo with Medical background

AREX Capital Management LP lifted its holdings in Enhabit, Inc. (NYSE:EHAB - Free Report) by 2.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,490,795 shares of the company's stock after purchasing an additional 48,874 shares during the period. Enhabit comprises 27.7% of AREX Capital Management LP's holdings, making the stock its biggest holding. AREX Capital Management LP owned about 4.95% of Enhabit worth $19,453,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. boosted its position in shares of Enhabit by 37.8% in the third quarter. JPMorgan Chase & Co. now owns 305,245 shares of the company's stock worth $2,411,000 after buying an additional 83,707 shares during the period. Paradice Investment Management LLC grew its stake in Enhabit by 12.8% during the 4th quarter. Paradice Investment Management LLC now owns 1,780,113 shares of the company's stock valued at $13,903,000 after acquiring an additional 201,997 shares in the last quarter. Corient Private Wealth LLC acquired a new position in shares of Enhabit in the 4th quarter valued at about $79,000. Rhumbline Advisers lifted its position in shares of Enhabit by 2.8% in the fourth quarter. Rhumbline Advisers now owns 80,760 shares of the company's stock worth $631,000 after purchasing an additional 2,211 shares in the last quarter. Finally, Empowered Funds LLC grew its position in Enhabit by 5.0% during the fourth quarter. Empowered Funds LLC now owns 175,824 shares of the company's stock valued at $1,373,000 after purchasing an additional 8,448 shares in the last quarter.

Enhabit Price Performance

Shares of EHAB traded up $1.24 during trading hours on Thursday, hitting $9.44. The stock had a trading volume of 342,881 shares, compared to its average volume of 481,129. The stock has a market capitalization of $478.01 million, a price-to-earnings ratio of -4.07 and a beta of 1.61. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.46 and a quick ratio of 1.46. The company's fifty day moving average is $8.26 and its two-hundred day moving average is $8.04. Enhabit, Inc. has a 52 week low of $6.85 and a 52 week high of $10.70.

Enhabit (NYSE:EHAB - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.10 EPS for the quarter, beating analysts' consensus estimates of $0.07 by $0.03. Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. The firm had revenue of $259.90 million for the quarter, compared to analyst estimates of $266.11 million. On average, analysts anticipate that Enhabit, Inc. will post 0.22 EPS for the current year.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group reiterated a "buy" rating on shares of Enhabit in a report on Thursday, March 6th.

View Our Latest Analysis on EHAB

About Enhabit

(Free Report)

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

Recommended Stories

Institutional Ownership by Quarter for Enhabit (NYSE:EHAB)

Should You Invest $1,000 in Enhabit Right Now?

Before you consider Enhabit, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enhabit wasn't on the list.

While Enhabit currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines